PAB 14.3% 0.6¢ patrys limited

Possible Major cancer breakthrouh, page-2

  1. 99 Posts.
    ""Patrys believes that Deoxymab, and its sister antibody, 5C6, may have application across a wide range of malignancies such as gliomas, melanomas, prostate, breast, pancreatic and ovarian cancers."(WORLDWIDE).

    Well we have to love this bit... and this is what I believe the breakthrough announcement will contain positive news about.
    GLOBALLY this could be extremely enormous for PAB. A VERY IMPORTANT AREA OF CANCER MEDICINE.
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.6¢
Change
-0.001(14.3%)
Mkt cap ! $12.34M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $1.953K 325.4K

Buyers (Bids)

No. Vol. Price($)
6 4291214 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 500160 1
View Market Depth
Last trade - 11.14am 06/09/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.